Camarda Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Camarda Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36,695	Closed	-$4.82M	–	70
2022 Q4	$4.82M	Buy	36,695 +18,900	+106%	+$2.44M	4.86%	1
2022 Q3	$2.08M	Buy	+17,795	New	+$2.21M	2.44%	7
2019 Q2	–	Sell	-98	Closed	-$11K	–	530
2019 Q1	$11K	Buy	+98	New	+$10.7K	0.02%	179
2015 Q3	–	Sell	-2,196	Closed	-$270K	–	187
2015 Q2	$270K	Buy	2,196 +1,290	+142%	+$154K	0.15%	66
2015 Q1	$104K	Buy	906 +525	+138%	+$57.9K	0.06%	100
2014 Q4	$39K	Buy	381 +159	+72%	+$15.5K	0.02%	141
2014 Q3	$20K	Buy	+222	New	+$19.5K	0.01%	161

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Camarda Financial Advisors's IBB Position: Q1 2023 in Review

Camarda Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 36,695 shares — an estimated $4.82M sold.

Camarda Financial Advisors first reported a position in IBB in Q3 2014 and held it in 7 quarters. The position peaked at $4.82M in Q4 2022. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

Camarda Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
Camarda Financial Advisors sold 36,695 iShares Biotechnology ETF shares in Q1 2023, an estimated $4.82M.
Camarda Financial Advisors first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 7 quarters.
Camarda Financial Advisors's iShares Biotechnology ETF position peaked at $4.82M in Q4 2022.
867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Camarda Financial Advisors's 13F filing for Q1 2023, filed 11 May 2023.